XtalPi Holdings Ltd
2228
Classifica tra le azioni
#4646
XtalPi Holdings Limited functions as an investment holding company, delivering... XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
Prezzo delle azioni
$0.74616501
Capitalizzazione di mercato
$3.21B
Variazione (1 giorno)
-4.10%
Variazione (1 anno)
-50.36%
Paese
CN
Scambia XtalPi Holdings Ltd (2228)
Categoria
Healthcare
Rapporto P/B per XtalPi Holdings Ltd (2228)
Rapporto P/B al October 2026 TTM: 2.26
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di XtalPi Holdings Ltd, il rapporto P/B attuale (TTM) è 2.26. Alla fine del 2024, era pari a 2.72.
Storico del rapporto P/B per XtalPi Holdings Ltd da 2024 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 2.26 | -33.91% |
| 2025 | 3.42 | 25.85% |
| 2024 | 2.72 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 6.251 | 176.56% |
US
|
|
| 13.2547 | 486.41% |
US
|
|
| 4.4521 | 96.97% |
AU
|
|
| 6.3632 | 181.52% |
NL
|
|
| - | - |
CH
|
